New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays ...
AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...
Collaborative research is underway to translate scientific discovery into actionable evidence ...
From protein translation to mitosis, fundamental cellular processes are multifaceted and dynamic. Researchers seeking to understand the inner workings of a cell benefit from multidisciplinary ...
AAA Bio’s recombinant proteins, offering high purity, consistency, and reliability for advancing research in drug ...
This poster was originally authored by John Vincent, Matthew Burnham, Gerrit Daubner, and Martin Main of the Medicines Discovery Catapult. It was presented at ELRIG Drug Discovery 2023. Methods to ...
Targeted protein degradation (TPD) is a promising alternative to conventional small-molecule drugs. Rather than inhibiting a single enzyme’s function, degrader molecules label selected ...
Morning Overview on MSN
Parkinson’s protein tied to faster Alzheimer’s tau buildup in women
A protein best known for its role in Parkinson’s disease may be speeding up Alzheimer’s-related brain damage in women. New ...
Morning Overview on MSN
Light-guided ‘optovolution’ creates proteins that flip states on cue
A peer-reviewed study published in Cell in March 2026 introduces “optovolution,” an in vivo directed-evolution system that uses light to breed proteins capable of switching between active and inactive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results